Editorial: ways to reduce emergency department utilisation among IBD patients (Englisch)
- Neue Suche nach: Mak, W. Y.
- Neue Suche nach: Ng, S. C.
- Neue Suche nach: Mak, W. Y.
- Neue Suche nach: Ng, S. C.
In:
Alimentary Pharmacology & Therapeutics
;
47
, 9
;
1325-1326
;
2018
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Editorial: ways to reduce emergency department utilisation among IBD patients
-
Beteiligte:Mak, W. Y. ( Autor:in ) / Ng, S. C. ( Autor:in )
-
Erschienen in:Alimentary Pharmacology & Therapeutics ; 47, 9 ; 1325-1326
-
Verlag:
-
Erscheinungsdatum:01.05.2018
-
Format / Umfang:2 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 47, Ausgabe 9
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1235
-
Issue Information| 2018
- 1238
-
Systematic review with meta‐analysis: neuroimaging in hepatitis C chronic infectionOriolo, G. / Egmond, E. / Mariño, Z. / Cavero, M. / Navines, R. / Zamarrenho, L. / Solà, R. / Pujol, J. / Bargallo, N. / Forns, X. et al. | 2018
- 1253
-
Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel diseaseVollebregt, P. F. / van Bodegraven, A. A. / Markus‐de Kwaadsteniet, T. M. L. / van der Horst, D. / Felt‐Bersma, R. J. F. et al. | 2018
- 1261
-
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strainsGatta, L. / Scarpignato, C. / Fiorini, G. / Belsey, J. / Saracino, I. M. / Ricci, C. / Vaira, D. et al. | 2018
- 1270
-
Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal diseaseTaft, T. H. / Triggs, J. R. / Carlson, D. A. / Guadagnoli, L. / Tomasino, K. N. / Keefer, L. / Pandolfino, J. E. et al. | 2018
- 1278
-
Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort studySinger, A. W. / Reddy, K. R. / Telep, L. E. / Osinusi, A. O. / Brainard, D. M. / Buti, M. / Chokkalingam, A. P. et al. | 2018
- 1288
-
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infectionvon Felden, J. / Vermehren, J. / Ingiliz, P. / Mauss, S. / Lutz, T. / Simon, K. G. / Busch, H. W. / Baumgarten, A. / Schewe, K. / Hueppe, D. et al. | 2018
- 1296
-
The adverse effects of interferon‐free regimens in 149 816 chronic hepatitis C treated Egyptian patientsAttia, D. / El Saeed, K. / Elakel, W. / El Baz, T. / Omar, A. / Yosry, A. / Elsayed, M. H. / Said, M. / El Raziky, M. / Anees, M. et al. | 2018
- 1306
-
Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patientsChuang, W.‐L. / Jia, J. / Chan, H. L. Y. / Han, K.‐H. / Tanwandee, T. / Tan, D. / Chen, X. / Gane, E. / Piratvisuth, T. / Chen, L. et al. | 2018
- 1317
-
Editorial: symptom association probability during reflux testing—what is the gain?Triggs, J. R. / Kahrilas, P. J. et al. | 2018
- 1318
-
Editorial: are the “miraculous” direct‐acting antiviral (DAA) regimens really safe?Papanikolaou, I. S. / Papadimitropoulos, V. et al. | 2018
- 1319
-
Editorial: patient‐reported outcomes in chronic HCV—a PROMISing approach to an ongoing problemAcharya, C. / Bajaj, J. S. et al. | 2018
- 1320
-
Editorial: patient‐reported outcomes in chronic HCV—a PROMISing approach to an ongoing problem. Authors' replyEvon, D. M. et al. | 2018
- 1321
-
Editorial: vancomycin – a promising option for the treatment of primary sclerosing cholangitis?Chapman, R. W. et al. | 2018
- 1323
-
Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease—following the fate of anti‐TNF‐alpha agents?Fragaki, M. / Karmiris, K. et al. | 2018
- 1324
-
Editorial: the sphincter of Oddi strikes again—eluxadoline illuminates a controversial mechanism for the pathogenesis of acute pancreatitisCoté, G. A. et al. | 2018
- 1325
-
Editorial: ways to reduce emergency department utilisation among IBD patientsMak, W. Y. / Ng, S. C. et al. | 2018
- 1327
-
Editorial: isolated duodenal eosinophilia—clinical condition or just seeing spots?Singh, P. / Leffler, D. A. et al. | 2018
- 1328
-
Editorial: optimal dose of carvedilol in portal hypertension…nearly thereTripathi, D. / Stanley, A. J. et al. | 2018
- 1329
-
Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' replyReiberger, T. / Ferlitsch, A. et al. | 2018
- 1330
-
Editorial: the prevalence of Helicobacter pylori infection worldwide—knowns and unknownsTsipotis, E. / Leontiadis, G. I. et al. | 2018
- 1331
-
Editorial: the prevalence of Helicobacter pylori infection worldwide—knowns and unknowns. Authors' replyZamani, M. / Derakhshan, M. H. / Zamani, V. / Shokri‐Shirvani, J. et al. | 2018
- 1332
-
Editorial: alleviating the itch—the safety of rifampicin in the real worldGordon‐Walker, T. T. et al. | 2018
- 1334
-
Letter: infliximab concentrations during induction therapy—one size does not fit allPapamichael, K. / Cheifetz, A. S. et al. | 2018